Ameriprise
TENX icon

Ameriprise’s Tenax Therapeutics TENX Stock Holding History

Ameriprise’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-279,537
Closed -$4.47M – 4249
2026
Q1 		$4.47M Buy
+279,537
New +$3.78M ﹤0.01% 2510
2021
Q3 		– Sell
-19
Closed -$62K – 3960
2021
Q2 		$62K Hold
19
– – ﹤0.01% 3848
2021
Q1 		$57K Hold
19
– – ﹤0.01% 3797
2020
Q4 		$56K Hold
19
– – ﹤0.01% 3719
2020
Q3 		$46K Hold
19
– – ﹤0.01% 3678
2020
Q2 		$27K Buy
+19
New +$27.9K ﹤0.01% 3637

Other funds holding TENX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Ameriprise's TENX Position: Q2 2026 in Review

Ameriprise sold out of Tenax Therapeutics (TENX) in Q2 2026, closing a stake of 279,537 shares — an estimated $4.47M sold.

Ameriprise first reported a position in TENX in Q2 2020 and held it in 6 quarters. The position peaked at $4.47M in Q1 2026. 111 funds tracked by Wall St. Rank hold TENX as of Q2 2026.

  • Ameriprise reported no remaining Tenax Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Ameriprise sold 279,537 Tenax Therapeutics shares in Q2 2026, an estimated $4.47M.
  • Ameriprise first reported a position in Tenax Therapeutics in Q2 2020 and held it in 6 quarters.
  • Ameriprise's Tenax Therapeutics position peaked at $4.47M in Q1 2026.
  • 111 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.